These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25925979)

  • 21. Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension.
    Fukumoto Y; Yamada N; Matsubara H; Mizoguchi M; Uchino K; Yao A; Kihara Y; Kawano M; Watanabe H; Takeda Y; Adachi T; Osanai S; Tanabe N; Inoue T; Kubo A; Ota Y; Fukuda K; Nakano T; Shimokawa H
    Circ J; 2013; 77(10):2619-25. PubMed ID: 23912836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome.
    Schinzari F; Tesauro M; Rovella V; Di Daniele N; Gentileschi P; Mores N; Campia U; Cardillo C
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E806-11. PubMed ID: 22829585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fasudil hydrochloride].
    Kitazono T
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():617-21. PubMed ID: 17461215
    [No Abstract]   [Full Text] [Related]  

  • 25. DL0805-1, a novel Rho-kinase inhibitor, attenuates lung injury and vasculopathy in a rat model of monocrotaline-induced pulmonary hypertension.
    Chen D; Yuan T; Chen Y; Zhang H; Niu Z; Fang L; Du G
    Eur J Pharmacol; 2022 Mar; 919():174779. PubMed ID: 35092757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.
    Jasińska-Stroschein M; Owczarek J; Łuczak A; Orszulak-Michalak D
    Pharmacology; 2013; 91(3-4):178-84. PubMed ID: 23428587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of fasudil on pulmonary hypertension in clinical practice.
    Zhang Y; Wu S
    Pulm Pharmacol Ther; 2017 Oct; 46():54-63. PubMed ID: 28782712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acute effects of 30 mg vs 60 mg of intravenous Fasudil on patients with congenital heart defects and severe pulmonary arterial hypertension.
    Ruan H; Zhang Y; Liu R; Yang X
    Congenit Heart Dis; 2019 Jul; 14(4):645-650. PubMed ID: 31166081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study.
    Zhang X; Zhang X; Wang S; Luo J; Zhao Z; Zheng C; Shen J
    Can Respir J; 2018; 2018():3148259. PubMed ID: 29785232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
    Gupta N; Rashid J; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
    Mol Pharm; 2017 Mar; 14(3):830-841. PubMed ID: 28165252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation.
    Zhao YD; Cai L; Mirza MK; Huang X; Geenen DL; Hofmann F; Yuan JX; Zhao YY
    Am J Pathol; 2012 Jun; 180(6):2268-75. PubMed ID: 22632818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis.
    Anegawa G; Kawanaka H; Yoshida D; Konishi K; Yamaguchi S; Kinjo N; Taketomi A; Hashizume M; Shimokawa H; Maehara Y
    Hepatology; 2008 Mar; 47(3):966-77. PubMed ID: 18167063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Rho kinase inhibitor Fasudil on late endothelial progenitor cells in peripheral blood of COPD patients with pulmonary artery hypertension.
    Liu P; Zhang H; Tang Y; Sheng C; Liu J; Zeng Y
    Bosn J Basic Med Sci; 2014 Feb; 14(1):40-4. PubMed ID: 24579970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of cerebral malaria by fasudil and other immune-modifying compounds.
    Waknine-Grinberg JH; McQuillan JA; Hunt N; Ginsburg H; Golenser J
    Exp Parasitol; 2010 Jun; 125(2):141-6. PubMed ID: 20093114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasodilatory effect of subsequent administration of fasudil, a rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris.
    Otsuka T; Ibuki C; Suzuki T; Ishii K; Kodani E; Atarashi H; Kishida H; Takano T
    Circ J; 2006 Apr; 70(4):402-8. PubMed ID: 16565555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasudil Is an Effective Graft Vasodilator for Gastroepiploic Artery in Coronary Artery Bypass Grafting.
    Watanabe G; Yamaguchi S; Tomita S; Nishida Y
    Innovations (Phila); 2015; 10(4):268-72; discussion 272. PubMed ID: 26360979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Rho kinase inhibitor fasudil on late endothelial progenitor cells in peripheral blood of COPD patients with pulmonary artery hypertension.
    Liu P; Zhang HM; Tang YJ; Sheng CF; Liu JX; Zeng YJ
    Bratisl Lek Listy; 2015; 116(3):150-3. PubMed ID: 25869561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Rho kinase inhibitor fasudil on the expression ET-1 and NO in rats with hypoxic pulmonary hypertension.
    Sun XZ; Li SY; Tian XY; Hong Z; Li JX
    Clin Hemorheol Microcirc; 2019; 71(1):3-8. PubMed ID: 29660902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: a review of preclinical and clinical studies.
    Satoh S; Ikegaki I; Kawasaki K; Asano T; Shibuya M
    Curr Vasc Pharmacol; 2014; 12(5):758-65. PubMed ID: 24923440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.